NR3C2 and breast cancer: In polarized epithelial cells, its primary target is the ligand aldosterone [32], NR3C2 is also involved in the development of various tumor cells, including pancreatic ductal adenocarcinoma [12], hepatocellular carcinoma [14, 15], and breast cancer [18, 19].